FDA.reportPublic FDA data

COMPOUND W WART REMOVER SALICYLIC ACID MAXIMUM STRENGTH FAST ACTING GEL + SHIELD

Manufacturer
ASO LLC
Effective date
2026-05-27
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 01:59:01

Label at a glance#

ProductCompound W
Active ingredientSALICYLIC ACID
Label structure9 sections

Dosage and administration

wash affected area may soak wart in warm water for 5 minutes dry area thoroughly by squeezing tube gently, apply one drop at a time to sufficiently cover each wart let dry repeat this procedure once or twice daily as needed (until wart is removed) for up to 12 weeks

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 17% w/w

PURPOSE

OTC - PURPOSE SECTION

Wart remover

USE

INDICATIONS & USAGE SECTION

  • for the removal of common and plantar warts.
  • the common wart is easily recognized by the rough “cauliflower-like” appearance on the surface.
  • the plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern.

WARNINGS

WARNINGS SECTION

For external use only.

Flammable. Keep away from fire and flame.

Do not use

OTC - DO NOT USE SECTION

  • on irritated skin or on any area that is infected or reddened.
  • on moles, birthmarks, warts with hair growing from them, genital warts or warts on the face or mucous membranes.
  • if you have diabetes or poor blood circulation.

When using this product

OTC - WHEN USING SECTION

  • avoid contact with eyes. If product gets into the eye, flush with water for 15 minutes.
  • avoid inhaling vapors
  • cap tightly and store at room temperature away from heat

Stop use and ask a doctor if

OTC - STOP USE SECTION

discomfort persists.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

  • wash affected area
  • may soak wart in warm water for 5 minutes
  • dry area thoroughly
  • by squeezing tube gently, apply one drop at a time to sufficiently cover each wart
  • let dry
  • repeat this procedure once or twice daily as needed (until wart is removed) for up to 12 weeks

OTHER INFORMATION

OTHER SAFETY INFORMATION

  • Apply gel to wart and let dry (for approx. 5 minutes after application), before covering the wart with the ProShield Patch.
  • store at room temperature
  • avoid excessive heat 37C (99F)
  • skin discoloration may accur during or after use
  • wipe the tip of the tube with a paper towel between uses

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

alcohol, camphor, castor oil, ethyl acetate, hydroxypropyl cellulose, hypophosphorous acid, isopropanol, nitrocellulose, polysorbate 80, water

QUESTIONS?

OTC - QUESTIONS SECTION

1-800-443-4908

CompoundW.com

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Compound W

WART REMOVER

Salicylic acid

MAXIMUM STRENGTH

FAST ACTING GEL + SHIELD

EFFECTIVELY SHIELDS & REMOVES WARTS

MADE FOR WARTS ON FEET

No Drip Gel

  • Maximum strength

ProShield Patches

  • Shields wart against rubbing

GEL NET WT 0.25 oz (7 g) I 12 PROSHIELD PATCHES

Part 2000057Part 2000057

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
210140Compound W 17 % Topical GelPSN5
312880salicylic acid 17 % Topical GelPSN5
210140salicylic acid 0.17 MG/MG Topical Gel [Compound W brand of salicylic acid]SBD5
312880salicylic acid 0.17 MG/MG Topical GelSCD5
210140Compound W brand of salicylic acid 0.17 MG/MG Topical GelSY5
210140Compound W brand of salicylic acid 17 % Topical GelSY5
312880salicylic acid 17 % Topical GelSY5

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130075137000308GTIN-13: 0075137000308
EAN-13: 0075137000308
GTIN-12: 075137000308
UPC-A: 075137000308
GTIN storage (14 digits): 00075137000308		Item_2000057_CPW_GEL_CONCE2.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51142-595-122022-09-15C16284748780-1e4f33bdf-9f3b-d8a0-e053-dadaa90a6e4eCOMPOUND W WART REMOVER SALICYLIC ACID MAXIMUM STRENGTH FAST ACTING GEL + SHIELD
51142-595-122022-07-29C16284748780-1e4f33bdf-9f3b-d8a0-e053-dadaa90a6e4eCOMPOUND W WART REMOVER SALICYLIC ACID MAXIMUM STRENGTH FAST ACTING GEL + SHIELD

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51142-595-12Compound W7 g in 1 TUBEGEL75
51142-595-12Compound W1 in 1 CARTONGEL15

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51142-59551142-595-12
49354-076

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
NameUNIIKind
SALICYLIC ACIDO414PZ4LPZACTIB
ETHYL ACETATE76845O8NMZIACT
CAMPHOR (NATURAL)N20HL7Q941IACT
CASTOR OILD5340Y2I9GIACT
HYPOPHOSPHOROUS ACID8B1RL9B4ZJIACT
POLYSORBATE 806OZP39ZG8HIACT
ALCOHOL3K9958V90MIACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PIACT
ISOPROPYL ALCOHOLND2M416302IACT
PYROXYLINKYR8BR2X6OIACT
WATER059QF0KO0RIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Compound WSALICYLIC ACID GELASO LLCb55c7421-a8fe-8d4e-e053-2a95a90a7a6f2026-05-27WarningsExact identifier
ndc (package): 51142-595-12
ndc (product): 51142-595
ndc11 (package): 51142059512
spl id: 52ccbaf1-bf0c-4adc-e063-6294a90ac8cc
spl set id: b55c7421-a8fe-8d4e-e053-2a95a90a7a6f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.